Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.

American journal of clinical pathology - 1 Dec 2008

Gomez-Fernandez Carmen, Daneshbod Yahya, Nassiri Mehdi, Milikowski Clara, Alvarez Consuelo, Nadji Mehrdad

Abstract excerpt

We evaluated the estrogen receptor (ER) phenotype of recurrent and/or metastatic breast cancers and compared it with the ER status of the primary tumor in 278 cases. All patients had undergone surgical excision of the primary tumor, followed by observation only or treatment modalities that included radiation and/or chemotherapy or hormonal therapy. The immunohistochemical expression of ER was evaluated by using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Neoplasm Metastasis

Share to Neoplasm Recurrence, Local

Share to Phenotype

Share to Receptors, Estrogen

Share to Time Factors

Source

Identifiers

PMID: 19019763
DOI: 10.1309/AJCPD1AO3YSYQYNW

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.PMID 19019763Read ↗

Estrogen receptor mutations and changes in estrogen receptor and progesterone receptor protein expression in metastatic or recurrent breast cancer.Semantic proximity Read ↗

Estrogen receptor expression profile of disseminated epithelial tumor cells in bone marrow of breast cancer patients.Semantic proximity Read ↗

ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.Semantic proximity Read ↗

Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entitiesSemantic proximity Read ↗

Gene Expression Profiles for Recurrence of Lymph Node-positive Primary Breast Cancer in Women Over 40 Years of AgeSemantic proximity Read ↗

HER2 Gene Amplification in ER-positive HER2 Immunohistochemistry 0 or 1+ Breast Cancer With Early Recurrence.Semantic proximity Read ↗

Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.Semantic proximity Read ↗

Oestrogen receptor: a stable phenotype in breast cancer.Semantic proximity Read ↗

Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast CancerSemantic proximity Read ↗

Variation of ER status between primary and metastatic breast cancer and relationship to p53 expression*.Semantic proximity Read ↗

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy.Semantic proximity Read ↗

Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative breast cancer: An ad-hoc analysis of the JBCRG-C06 Safari studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.